Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
20,224,271
-
Share change
-
+3,333,034
-
Total reported value
-
$164,053,284
-
Put/Call ratio
-
1.4%
-
Price per share
-
$8.10
-
Number of holders
-
68
-
Value change
-
+$27,070,509
-
Number of buys
-
23
-
Number of sells
-
35
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q1 2017
As of 31 Mar 2017,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,224,271 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, StepStone Group LP, HIGHLINE CAPITAL MANAGEMENT, L.P., PEREGRINE CAPITAL MANAGEMENT LLC, STATE STREET CORP, NORTHERN TRUST CORP, COURAGE CAPITAL MANAGEMENT LLC, and Rock Springs Capital Management LP.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.